[Chronic liver diseases: what physicians and patients hope for. New strategies against liver cell death].
Vetter
Christine
C
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D053181:Caspase 8; D053453:Caspase 9; D061945:Caspase Inhibitors; D015198:Designer Drugs / Q000627:therapeutic use*; D006801:Humans; D015850:Interleukin-6 / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D017093:Liver Failure / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D061945:Caspase Inhibitors; D015198:Designer Drugs; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; C505530:CASP8 protein, human; C506433:CASP9 protein, human; D053181:Caspase 8; D053453:Caspase 9